Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Tenaya Therapeutics, Inc. | 120,000 | reported | 28 May 2026 | tx 5+316,166 |
| DiaMedica Therapeutics Inc. | 73,288 | reported | 03 Jan 2023 | tx 5+105,296 |
| Terns Pharmaceuticals, Inc. | 0 | reported | 05 May 2026 | tx 36+3,233,740−3,249,187 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 28 May 2026 | GRANT_AWARD | Tenaya Therapeutics, Inc. | 120,000 | 0.00 USD | deriv |
| 05 May 2026 | TENDER | Terns Pharmaceuticals, Inc. | 146,614 | 53.00 USD | |
| 05 May 2026 | TENDER | Terns Pharmaceuticals, Inc. | 8,319 | 53.00 USD | |
| 05 May 2026 | OTHER | Terns Pharmaceuticals, Inc. | 150,000 | 53.00 USD | |
| 05 May 2026 | OTHER | Terns Pharmaceuticals, Inc. | 955,534 | — | deriv |
| 05 May 2026 | OTHER | Terns Pharmaceuticals, Inc. | 1,250,000 | — | deriv |
| 05 May 2026 | OTHER | Terns Pharmaceuticals, Inc. | 300,000 | — | deriv |
| 16 Mar 2026 | SALE | Terns Pharmaceuticals, Inc. | 2,770 | 47.30 USD | |
| 16 Mar 2026 | EXERCISE | Terns Pharmaceuticals, Inc. | 14,583 | 4.64 USD | |
| 16 Mar 2026 | SALE | Terns Pharmaceuticals, Inc. | 11,813 | 46.57 USD | |
| 16 Mar 2026 | EXERCISE | Terns Pharmaceuticals, Inc. | 14,583 | 0.00 USD | deriv |
| 17 Feb 2026 | SALE | Terns Pharmaceuticals, Inc. | 4,083 | 39.80 USD | |
| 17 Feb 2026 | SALE | Terns Pharmaceuticals, Inc. | 8,159 | 39.22 USD | |
| 17 Feb 2026 | SALE | Terns Pharmaceuticals, Inc. | 2,341 | 38.07 USD | |
| 17 Feb 2026 | EXERCISE | Terns Pharmaceuticals, Inc. | 14,583 | 4.64 USD | |
| 17 Feb 2026 | EXERCISE | Terns Pharmaceuticals, Inc. | 14,583 | 0.00 USD | deriv |
| 14 Jan 2026 | GRANT_AWARD | Terns Pharmaceuticals, Inc. | 150,000 | 0.00 USD | |
| 15 Jan 2026 | EXERCISE | Terns Pharmaceuticals, Inc. | 27,083 | 4.64 USD | |
| 15 Jan 2026 | EXERCISE | Terns Pharmaceuticals, Inc. | 27,083 | 4.64 USD | |
| 15 Jan 2026 | EXERCISE | Terns Pharmaceuticals, Inc. | 14,583 | 4.64 USD | |
| 15 Jan 2026 | SALE | Terns Pharmaceuticals, Inc. | 61,228 | 37.02 USD | |
| 15 Jan 2026 | SALE | Terns Pharmaceuticals, Inc. | 7,521 | 37.53 USD | |
| 15 Jan 2026 | EXERCISE | Terns Pharmaceuticals, Inc. | 14,583 | 0.00 USD | deriv |
| 15 Jan 2026 | EXERCISE | Terns Pharmaceuticals, Inc. | 27,083 | 0.00 USD | deriv |
| 15 Jan 2026 | EXERCISE | Terns Pharmaceuticals, Inc. | 27,083 | 0.00 USD | deriv |
1 purchase reported after at least 12 months of silence — most recent on 30 Nov 2024.